Coronavirus information from UCLA and UCLA Health
The CNSI will re-open on June 12 for projects with approved Research Ramp-Up Plans.


The Next Generation Incubator

Ferrologix uses magnetic nanotechnology to accelerate research and manufacturing of cellular therapies.

Cell purification remains a critical need in development and production of cutting edge diagnostics and therapeutics. Ferrologix has a unique magnetic based instrument & disposable cartridge that can transport, filter, and organize single cells for precision analysis or therapeutic manufacture. Pioneering a technique called Ratcheting Cytometry, Ferrologix is developing a suite of tools to assist, accelerate, and scale the development of cell based therapies and immunotherapies. Various designs can execute a variety of functions such as rapid purification, quantitative separation based on cell surface expression, and multi-parameter/multi-marker cell sorting.

Graduated in 2018
Location: Torrance, CA